Cardiovascular outcome studies including LEADER and SUSTAIN-6 confirmed that GLP-1 medications reduce heart attack and stroke risk in people with established type 2 diabetes, an effect that persists when patients concurrently use metformin
Orlistat may support maintenance if dietary fat remains low
This baseline allows clinicians to identify pre-existing deficiencies that amplify hair loss risk and to tailor supplementation and dosing strategies to individual needs
The most common side effects across all GLP-1 receptor agonists are nausea, vomiting, diarrhea, and constipation typically occurring during the dose escalation period and resolving within 48 weeks
We also thank curegpx4.org for supporting the study and patients with GPX4 variants, and the roadmap effort for GPX4 disorders 46
By activating GLP-1 receptors in the brain, semaglutide helps reduce hunger and calorie intake, making it effective for managing type 2 diabetes and promoting weight loss
